Date of filling in this questionnaire or last update: 14/07/2020
1. IDENTIFICATION & BASIC DESCRIPTION
Cohort name
UK Biobank
Country
  • United Kingdom
Please provide any other information on the cohort location/s if needed
National survey, England and Wales
Name
Rory Collins
Institution
University of Oxford
Email
rory.collins@ndph.ox.ac.uk
Website
  • https://www.ukbiobank.ac.uk/
Name of committee
Multiple
Or provide website
  • https://www.ukbiobank.ac.uk/key-documents/
Data access policy (briefly describe)
http://www.ukbiobank.ac.uk/wp-content/uploads/2012/09/Access-Procedures-2011.pdf
Upload files
Main aim of cohort, please briefly describe the main objectives of the cohort
This is a general population all-purpose cohort of adults, which includes some occupational data.
Study design (please select as many as appropriate)
  • Prospective cohort
Source population (please select as many as appropriate)
  • General population: National
Comparators (please select as many as appropriate)
  • Internal study population
Enrollment
Completed
Age range at entry (main cohort)
Minimum Maximum Mean
40 69 55
Men at enrollment
250,000
Women at enrollment
250,000
Children (<18 years) at enrollment
0
Men at last follow-up
250,000
Women at last follow-up
250,000
Participation rate at enrollment (if known)
5
Comments
Access is open to all - apply through through the website - there is no need to contact the Principal Investigator
2. OUTCOME FOLLOW-UP
Type of data for outcome follow-up (please select as many as appropriate)
  • Active (contact with participants)
  • Death certificate
  • Disease incidence records
  • Hospital / physician diagnoses
Active (contact with participants) (specify)
  • Only for special surveys
Death certificate (specify)
  • Routine linkage
Disease incidence records (specify)
  • Routine linkage, e.g. to cancer registries
Hospital / Physician diagnoses (specify)
  • Linkage with hospital admissions
First follow-up period (provide year)
2006
Last follow-up period (provide year)
ongoing
Number of follow-ups after baseline (provide number)
500,000
Participation at last follow-up (if known)
100
Comments
Most follow-up is routine record linkage and is therefore close to 100%
3. OCCUPATIONAL EXPOSURES
Source of exposure data collected (please select as many as appropriate)
  • Questionnaire, Personal (Self-reporting or interview)
  • Questionnaire, Personal (Occupational/industry modules)
Occupational history/time frame
Lifetime
Occupational coding performed
No
4. OUTCOMES EVALUATED
Baseline - type of outcome data collected (select more than one if applicable)
  • Biomarker (specify)
  • Clinical/functional evaluation, e.g. spirometry, ECGs (specify)
  • Death certificates
  • Registry-based
Specify: Clinical/functional evaluation, e.g. spirometry, ECGs
Many
Specify: Biomarker
Many
Registry-based
  • Cancer incidence
Follow-up - type of outcome data collected (select more than one if applicable)
  • Death certificates
  • Medical records
Outcome type (please select as many as appropriate)
  • Mortality
  • Morbidity
Other health related outcomes
  • Biomarkers
5. BIOLOGICAL SAMPLES & ANALYSIS
Biological samples collected
  • Blood
Biological processing
  • DNA
6. Other Information
Possibility for linkage to data registries/data enrichment via data linkage
  • Cancer incidence
  • Hospital discharge
Please describe plans that are funded or most likely to be funded
The cohort is gathering more information all of the time, particularly with record linkage